VERU
Veru Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.64
−0.38%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-48.0%
Return on equity
-36.8%
Return on assets
-61.8%
Return on invested capital
0.00x
Asset turnover
-$26.0M
Cash from operations
$1.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026